Clinical characteristics and outcome of childhood acute promyelocitic leukemia (APL) in Saudi Arabia: a multicenter SAPHOS leukemia group study

References

• Testi AM, D’Angio M, Locatelli F, et al. Acute promyelocytic leukemia (APL): comparison between children and adults. Mediterr J Hematol Infect Dis. 2014;6(1):e2014032. doi: 10.4084/mjhid.2014.032
   PubMedGoogle Scholar
• Maule MM, Dama E, Mosso ML, et al. High incidence of acute promyelocytic leukemia in children in northwest Italy, 1980-2003: a report from the childhood cancer registry of piedmont. Leukemia. 2008;22(2):439–441. doi: 10.1038/sj.leu.2404916
   PubMed Web of Science ®Google Scholar
• Long ZJ, Hu Y, Li XD, et al. ATO/ATRA/anthracycline-chemotherapy sequential consolidation achieves long-term efficacy in primary acute promyelocytic leukemia. PLoS ONE. 2014;9(8):e104610. doi: 10.1371/journal.pone.0104610
   PubMed Web of Science ®Google Scholar
• Li EQ, Xu L, Zhang ZQ, et al. Retrospective analysis of 119 cases of pediatric acute promyelocytic leukemia: comparisons of four treatment regimes. Exp Ther Med. 2012;4(1):93–98. doi: 10.3892/etm.2012.546
   PubMed Web of Science ®Google Scholar
• Bally C, Fadlallah J, Leverger G, et al. Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL Group. J Clin Oncol. 2012;30(14):1641–1646. doi: 10.1200/JCO.2011.38.4560
   PubMed Web of Science ®Google Scholar
• Wang H, Hao L, Wang X, et al. Retrospective study of arsenic trioxide for childhood acute promyelocytic leukemia in China: a single-center experience. Int J Hematol. 2010;91(5):820–825. doi: 10.1007/s12185-010-0575-z
   PubMed Web of Science ®Google Scholar
• Kim MH, Choi CS, Lee JW, et al. Outcome of childhood acute promyelocytic leukemia treated using a modified AIDA protocol. Korean J Hematol. 2010;45(4):236–241. doi: 10.5045/kjh.2010.45.4.236
   PubMedGoogle Scholar
• Powell BL, Moser B, Stock W, et al. Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American leukemia intergroup study C9710. Blood. 2010;116(19):3751–3757. doi: 10.1182/blood-2010-02-269621
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhao H, Zhu X, et al. Retrospective analysis of 65 Chinese children with acute promyelocytic leukemia: a single center experience. Pediatr Blood Cancer. 2008;51(2):210–215. doi: 10.1002/pbc.21510
   PubMed Web of Science ®Google Scholar
• Ortega JJ, Madero L, Martin G, et al. Treatment with all- trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group. J Clin Oncol. 2005;23(30):7632–7640. doi: 10.1200/JCO.2005.01.3359
   PubMed Web of Science ®Google Scholar
• Testi AM, Biondi A, Lo Coco F, et al. GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. Blood. 2005;106(2):447–453. doi: 10.1182/blood-2004-05-1971
   PubMed Web of Science ®Google Scholar
• de Botton S, Coiteux V, Chevret S, et al. Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy. J Clin Oncol. 2004;22(8):1404–1412. doi: 10.1200/JCO.2004.09.008
   PubMed Web of Science ®Google Scholar
• Testa U, Lo-Coco F. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients. Ann Hematol. 2016;95(5):673–680. doi: 10.1007/s00277-016-2622-1
   PubMed Web of Science ®Google Scholar
• Farah RA, Horkos JG, Bustros YD, et al. A multicenter experience from Lebanon in childhood and adolescent acute myeloid leukemia: high rate of early death in childhood acute promyelocytic leukemia. Mediterr J Hematol Infect Dis. 2014;7(1):e2015012. doi: 10.4084/mjhid.2015.012
   Google Scholar
• Shepshelovich D, Edel Y, Goldvaser H, et al. Pharmacodynamics of cytarabine induced leucopenia: a retrospective cohort study. Br J Clin Pharmacol. 2015;79(4):685–691. doi: 10.1111/bcp.12530
   PubMed Web of Science ®Google Scholar
• Sanz MA, Martin G, Rayon C, et al. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group. Blood. 1999;94(9):3015–3021.
   PubMed Web of Science ®Google Scholar
• Montesinos P, Gonzalez JD, Gonzalez J, et al. Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic acid and anthracycline-based chemotherapy. J Clin Oncol. 2010;28(24):3872–3879. doi: 10.1200/JCO.2010.29.2268
   PubMed Web of Science ®Google Scholar
• Cull EH, Altman JK. Contemporary treatment of APL. Curr Hematol Malig Rep. 2014;9(2):193–201. doi: 10.1007/s11899-014-0205-6
   PubMed Web of Science ®Google Scholar
• Correa de Araujo Koury L, Ganser A, Berliner N, et al. Treating acute promyelocytic leukaemia in Latin America: lessons from the international consortium on acute leukaemia experience. Br J Haematol. 2017;177(6):979–983. doi: 10.1111/bjh.14589
   PubMed Web of Science ®Google Scholar
• Hassan IB, Zaabi MRA, Alam A, et al. Characteristics features and factors influencing early death in acute promyelocytic leukemia; experience from United Arab Emirates (UAE). Int J Hematol. 2017;106(1):90–98. doi: 10.1007/s12185-017-2211-7
   PubMed Web of Science ®Google Scholar
• World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194. doi: 10.1001/jama.2013.281053
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381. doi: 10.1016/j.jbi.2008.08.010
   PubMed Web of Science ®Google Scholar
• R Core Team. 2017 29 May 2017. R: a language and environment for statistical computing. R Foundation for Statistical Computing. [cited May 2017]. Available from: https://www.R-project.org/
   Google Scholar
• Chow S, Shao J HW. Sample size calculations in clinical research. Boca Raton (FL): Chapman & Hall/CRC Biostatistics; 2008.
   Google Scholar
• Kutny MA, Alonzo TA, Gerbing RB, et al. Results of a phase III trial including arsenic trioxide consolidation for pediatric patients with acute promyelocytic leukemia (APL): a report from the Children’s Oncology Group study AAML0631. Blood. 2015;126:219.
   Web of Science ®Google Scholar
• Imaizumi M, Tawa A, Hanada R, et al. Prospective study of a therapeutic regimen with all-trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: the Japanese childhood acute myeloid leukaemia cooperative study. Br J Haematol. 2011;152(1):89–98. doi: 10.1111/j.1365-2141.2010.08332.x
   PubMed Web of Science ®Google Scholar